begin with a free consultation (949) 870-3800
begin with a free consultation
begin with a free consultation (949) 870-3800
begin with a free consultation
begin with a free consultation Start Here
start a free consultation here
Every story is unique, start telling yours here
  • This field is for validation purposes and should be left unchanged.
All Fields Required

Allergan Breast Implant Cancer Attorney

Are you or a loved one concerned about the world-wide recall of Allergan breast implants? At Bentley & More, our attorneys can help.

In July 2019, the Food and Drug Administration (FDA) issued a recall of the following Allergan Biocell textured breast implants due to significantly high cases of a rare cancer directly linked to the product:

  • Natrelle saline-filled implants
  • Natrelle silicone-filled implants
  • Natrelle Inspira silicone-filled implants
  • Natrelle 410 highly cohesive anatomically shaped silicone-filled breast implants
  • Tissue expanders, including the Natrelle 133 Plus Tissue Expander and Natrelle 133 Tissue Expander with Suture Tab

If you were affected by this recall – even if you do not yet exhibit symptoms – or a loved one has contracted cancer due to any of the above Allergan implants, please contact the Allergan breast implant cancer attorneys at Bentley & More immediately to discuss your case. You may be entitled to significant compensation for any injuries incurred as a result of their negligence.

What’s Wrong with the Allergan Breast Implant?

Allergan breast implants have been directly linked to a rare and deadly form of cancer. Allergan is one of the primary manufacturers of breast implants, with operations in more than 100 countries.  For years, there have been emerging issues with Allergan’s textured breast implant surfaces contributing to cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL), a type of cancer of the immune system.

According to an FDA report, those who have Allergan Biocell textured breast implants are at an increasingly high risk of developing breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Over the last several years, Allergan implants have been associated with nearly 84 percent of breast implant-associated anaplastic large cell lymphoma cases worldwide.

Through it’s investigation, the FDA identified 573 cases of BIA-ALCL and 33 deaths worldwide. Of those cases, 481 have been directly linked to Allergan implants – a rate six times higher than that of other textured implants sold in the country.  In cases where BIA-ALCL has caused death, the manufacturer has overwhelmingly been associated with Allergan.

On July 24, 2019, the FDA finally took action, requesting that Allergan issue a voluntary recall of its BIOCELL textured breast implants and tissue expanders.  Allergan has now recalled a broad swath of its products from the marketplace.  Although these Allergan products are thought to account for a relatively modest market share, the risk of BIA-ALCL is one that can cause severe injury and even death.  The FDA is advising consumers to closely monitor themselves for symptoms, and to confer with their physicians to discover if their implants are one of the affected model lines.

What is Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)?

BIA-ALCL is a rare form of lymphoma.  It is not a breast cancer but rather a cancer of the immune system. This disease affects patients who have received breast implants, textured breast implants in particular.  Lymphoma cells develop in the scar tissue and any fluids surrounding the breast implant, and it may take up to 10 years for symptoms to appear, which include:

  • Pain and tenderness near breast implant sites
  • Swelling near breast implants
  • Unexplained skin irritation
  • Sudden fatigue
  • Lumps
  • Redness
  • Change in the size or shape of the breast or breasts

BIA-ACL progress slowly and can spread to the lymph nodes in other areas of the body, where it may be fatal.  If you experience any of these symptoms or have received any of the recalled implants manufactured by Allergan, contact a medical professional immediately to schedule an evaluation.

What Can I Do If I Have Allergan Breast Implants?

If you have any type of Allergan Biocell implants, surgery to remove them is currently not required, but a follow-up with a medical professional is highly advised to ensure you are safe.

If you are affected by this recall, even if you do not yet exhibit symptoms, we highly advise you to discuss your potential case with a Orange County personal injury attorney to help evaluate any potential claims against Allergan for its faulty, potentially fatal products. Although the FDA is not yet recommending removal for those without symptoms, this field is one that may quickly change, and Allergan’s failures have caused untold stress, anxiety, and worry for its consumers across the country. Bentley & More LLP offers a suite of skilled, experienced product liability lawyers who are evaluating potential product liability claims against Allergan, and provides free consultations and case evaluations to help women determine whether financial compensation may be available as a result of this recall.

Allergan May Be Liable for Your Injuries

The safety risks associated with textured breast implants were under investigation dating as far back as 2017 – yet Allergan refused to voluntarily recall their Biocell implants until they were required to by law. Additionally, Allergan continued to sell their textured implants even though they were recalled in Canada two months ago and in Europe 7 months ago.

We believe that Allergan displayed gross negligence by continuing to sell their products despite knowing the risks associated with them. Therefore, they deserve to be held fully liable for any damages and injuries that resulted from the use of their products.

If you have Allergan Biocell textured breast implants and have developed BIA-ALCL, contact our Allergan breast implant cancer lawyers immediately to discuss your case. We want to help you receive the compensation that you deserve, and hold Allergan accountable for their negligent actions.